WESTMINSTER, Colo. and IRVINE, Calif.—May, 6, 2003— Masimo Corporation, the Irvine, Calif.-based innovator and leader of motion and low perfusion tolerant pulse oximetry, has joined Global Healthcare Exchange, LLC (GHX) in order to make it easier and more efficient for hospitals to purchase its advanced medical signal processing products used for the non-invasive monitoring of patient vital signs. Masimo has developed a unique pulse oximetry technology that can measure the oxygen in a patient’s blood even when the patient is moving or when signal amplitude is low, and which has proven particularly valuable in the treatment of infants and adults at risk of respiratory and cardiac distress. With over 100 percent growth year to year since commercialization of its Signal Extraction Pulse Oximeter, Masimo is the fastest growing pulse oximetry company in the world. “Since its inception in 1989, Masimo has strived to not only improve patient care but also to reduce the cost of care through the development of reliable patient monitoring technology,” says Kevin Mosher, President, Americas, Masimo Corporation. “By creating an opportunity for all members of the healthcare supply chain to participate in an open and neutral trading exchange, GHX should make it easier for hospitals around the world to purchase our products.” More than 1300 healthcare providers and 100 suppliers currently transact business electronically with one another via GHX in the United States. GHX also operates similar trading exchanges in Canada and Europe.
Masimo has demonstrated through independent clinical studies how the accuracy and reliability of its SET (Signal Extraction TechnologyÒ) Pulse Oximetry can save hospitals money and enable clinicians to focus on managing patient care as opposed to managing equipment. “While we are different companies with very different product offerings, Masimo and GHX’s philosophies are quite similar,” says GHX Chief Executive Officer Mike Mahoney. “By improving the accuracy of purchasing transactions and providing a reliable means to automate the procurement process, we are helping hospitals focus more on what they do best, providing quality patient care, while helping reduce overall supply chain costs through greater process efficiencies.”
About Masimo Corporation
Masimo Corporation, founded in 1989, is the innovator and leader of motion and low perfusion tolerant pulse oximetry. Masimo develops, licenses and markets advanced medical signal processing technologies and products for the non-invasive monitoring of vital signs. Masimo Signal Extraction Technology represents a fundamental departure from conventional pulse oximetry technologies. Over 50 independent and objective published studies have demonstrated that Masimo Signal Extraction Technology substantially overcomes the limitations of conventional pulse oximeters in accurately measuring arterial blood oxygen saturation levels and pulse rates in the presence of patient movement and low perfusion. To date, Masimo has licensed its Signal Extraction pulse oximetry technology to over 35 international patient monitoring system providers, which make up over 60 percent of the world’s pulse oximeter shipments. Leading group purchasing organizations, such as AmeriNet, Broadlane, HealthTrust and Premier, are offering their member hospitals the ability to gain access to Masimo SET oximetry. Masimo is headquartered in Irvine, California. Additional information about Masimo and its products can be found on the company's web site: www.masimo.com.
About Global Healthcare Exchange
Global Healthcare Exchange, LLC (GHX) provides an open and neutral electronic trading exchange, along with complementary products and services, through which buyers and sellers can collaborate to improve efficiencies in the healthcare supply chain. GHX’s catalog and content services improve the accuracy of purchasing transactions, reducing many of the most common and costly problems in healthcare procurement, while the privately held company’s revenue neutral business model is designed to lower costs for all involved. GHX’s owners, strategic partners and trading exchange participants are representative of the entire healthcare supply chain, including suppliers and distributors; integrated delivery networks (IDNs), hospitals and ancillary healthcare facilities; group purchasing organizations and their proprietary healthcare trading exchanges; and supply chain technology companies. Equity owners of GHX include Johnson & Johnson Health Care; GE Medical Systems; Baxter Healthcare Corp.; Medtronic USA, Inc.; Abbott Exchange, Inc.; Siemens; Becton, Dickinson & Co.; Boston Scientific Corp. Tyco Healthcare Group, LP; Guidant Corp.; C.R. Bard, Inc.; AmerisourceBergen Corp.; Cardinal Health, Inc.; Fisher Scientific International, Inc.; McKesson Corp.; B Braun Medical Inc.; Premier, Inc. and HCA. For more information visit www.ghx.com.